Crestline Management’s Xylem XYL Stock Holding History

Crestline Management’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,500	Closed	-$1.42M	–	882
2024 Q3	$1.42M	Buy	+10,500	New	+$1.4M	0.07%	228

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crestline Management's XYL Position: Q4 2024 in Review

Crestline Management sold out of Xylem (XYL) in Q4 2024, closing a stake of 10,500 shares — an estimated $1.42M sold.

Crestline Management first reported a position in XYL in Q3 2024 and held it in 1 quarter. The position peaked at $1.42M in Q3 2024. 1,001 funds tracked by Wall St. Rank hold XYL as of Q4 2024.

Crestline Management reported no remaining Xylem position as of Q4 2024 after selling out during the quarter.
Crestline Management sold 10,500 Xylem shares in Q4 2024, an estimated $1.42M.
Crestline Management first reported a position in Xylem in Q3 2024 and held it in 1 quarter.
Crestline Management's Xylem position peaked at $1.42M in Q3 2024.
1,001 funds tracked by Wall St. Rank held Xylem as of Q4 2024.

Based on Crestline Management's 13F filing for Q4 2024, filed 14 Feb 2025.